藥物研發是一段漫長且昂貴的過程，通常從一個健全的科學理論開始，在人類身上試藥之前，要先在實驗室中對動物進行廣泛的試驗。且必須在人體實驗的各個階段都是有成效的，才能有效治療患者。美秀博士將藉著這次演講，分享幾個新藥研發的故事，歡迎參加。 

Mei-Hsiu Ling joined Vertex in 2012 as the Biostatistics head for Hepatitis C franchise and currently leads the Cystic Fibrosis franchise and is the department head for the statistical programming group. Prior to joining Vertex, Dr. Ling was Global Program Head of Respiratory franchise at Novartis. She has more than 20 years of experience in late phase drug development. She is a board of director (and the president, 2016) for Monte Jade New England (mj-ne.org) and will serve as an executive committee member for Global Monte Jade in 2017. 

主辦：波士頓--台灣知識交流平台(Boston-Taiwan Platform)、清大圖書館 
https://www.meetup.com/Hsinchu-Open-Innovation…/…/236005099/